DRREDDY vs MAXHEALTH: Stock Comparison
Dr Reddys Laboratories Ltd is the larger company by market capitalisation. Dr Reddys Laboratories Ltd shows a lower P/E, a higher dividend yield and lower leverage, while Max Healthcare Institute Ltd shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 5; MAXHEALTH leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | MAXHEALTH |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Hospital |
Price
| Metric | DRREDDY | MAXHEALTH |
|---|---|---|
| Live Price | ₹1,200 | ₹1,007.5 |
| Day Change | -0.41% | -3.13% |
| Volume | 23.67 L | 27.63 L |
| 52-Week High | ₹1,414.9 | ₹1,301.7 |
| 52-Week Low | ₹1,101 | ₹903 |
| Distance from 52W High | -15.19% | -22.6% |
Valuation
| Metric | DRREDDY | MAXHEALTH |
|---|---|---|
| Market Cap | ₹1 L Cr | ₹97,947 Cr |
| P/E Ratio | 31.05x | 68.02x |
| P/B Ratio | 2.64x | 9.13x |
| EPS | ₹41.33 | ₹14.8 |
| Book Value | ₹460.31 | ₹110 |
| Dividend Yield | 0.69% | 0.18% |
Growth
| Metric | DRREDDY | MAXHEALTH |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | 12.2% |
| EPS Growth (TTM YoY) | -86.2% | 7.3% |
| Qtr Sales Growth | -11.5% | 12.2% |
| Qtr Profit Growth | -86.1% | 7.28% |
Profitability & Leverage
| Metric | DRREDDY | MAXHEALTH |
|---|---|---|
| ROE | 11.2% | 14.7% |
| ROCE | 13% | 14.7% |
| Net Margin | 12.76% | 17.23% |
| Operating Margin | 19.2% | 26.8% |
| Debt to Equity | 0.2x | 0.32x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | MAXHEALTH |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | 23.71% |
| FII Holding | 32.07%▼ 1.01 pp | 41.78%▼ 3.61 pp |
| DII Holding | 31.74%▲ 1.02 pp | 29.96%▲ 3.64 pp |
| Public Holding | 9.35%▲ 0.02 pp | 4.56%▼ 0.01 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and Max Healthcare Institute Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.